EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo

Grace Kaul, Abdul Akhir, Manjulika Shukla, Hasham Shafi, Ravikumar Akunuri, Gaurav Pawar, Mahammad Ghouse, Nanduri Srinivas, Sidharth Chopra iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.05031-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Grace Kaul und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus , which causes the majority of nosocomial and community-acquired infections globally, is a WHO high-priority pathogen for antibiotic research and development. In addition to invasive infections, it is the causative agent of moderate to severe skin infections, with an increasing prevalence of infections caused by MDR strains such as methicillin-resistant S. aureus (MRSA).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansAnimalsMiceStaphylococcus aureusGentamicinsAntifungal AgentsMicrobial Sensitivity TestsAnti-Bacterial AgentsImidazoles

Stichwörter der Autor:innen

Staphylococcus aureusdrug repurposingdrug resistancemultidrug resistanceoxiconazole

Substanzen

GentamicinsAntifungal AgentsAnti-Bacterial AgentsoxiconazoleImidazoles

Autor:innen und Institutionen

  • Division of Molecular Microbiology and Immunology, Lucknow, Uttar Pradesh, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Division of Pharmaceutics & Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
  • Department of Chemical Sciences, NIPER Hyderabad, Hyderabad, Telengana, India.

ORCID-Profile: Sidharth Chopra

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India

Zitieren

APA

Kaul, G., Akhir, A., Shukla, M., Shafi, H., Akunuri, R., Pawar, G., Ghouse, M., Srinivas, N., & Chopra, S. (2023). Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05031-22

Vancouver

Kaul G, Akhir A, Shukla M, Shafi H, Akunuri R, Pawar G, et al. Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo. Microbiology Spectrum. 2023. doi:10.1128/spectrum.05031-22

BibTeX
@article{Kaul2023,
  author = {Kaul, Grace and Akhir, Abdul and Shukla, Manjulika and Shafi, Hasham and Akunuri, Ravikumar and Pawar, Gaurav and Ghouse, Mahammad and Srinivas, Nanduri and Chopra, Sidharth},
  title = {Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus In Vitro and In Vivo},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.05031-22}
}
Kostenlos starten →